Ameritas Investment Partners’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Ameritas Investment Partners’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-5,256	Closed	-$145K	–	3098
2021 Q2	$145K	Sell	5,256 -552	-10%	-$10.8K	0.01%	1495
2021 Q1	$96K	Hold	5,808	–	–	﹤0.01%	1700
2020 Q4	$107K	Hold	5,808	–	–	﹤0.01%	1553
2020 Q3	$79K	Buy	5,808 +1,337	+30%	+$20.6K	﹤0.01%	1581
2020 Q2	$80K	Buy	4,471 +2,035	+84%	+$30.7K	﹤0.01%	1557
2020 Q1	$24K	Hold	2,436	–	–	﹤0.01%	2085
2019 Q4	$20K	Hold	2,436	–	–	﹤0.01%	2422
2019 Q3	$24K	Hold	2,436	–	–	﹤0.01%	2305
2019 Q2	$31K	Hold	2,436	–	–	﹤0.01%	2193
2019 Q1	$25K	Buy	2,436 +1,686	+225%	+$12.9K	﹤0.01%	2274
2018 Q4	$6K	Hold	750	–	–	﹤0.01%	2839
2018 Q3	$8K	Buy	+750	New	+$8.73K	﹤0.01%	2903

Ameritas Investment Partners's TBIO Position: Q3 2021 in Review

Ameritas Investment Partners sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 5,256 shares — an estimated $145K sold.

Ameritas Investment Partners first reported a position in TBIO in Q3 2018 and held it in 12 quarters. The position peaked at $145K in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

Ameritas Investment Partners reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Ameritas Investment Partners sold 5,256 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $145K.
Ameritas Investment Partners first reported a position in Translate Bio, Inc. Common Stock in Q3 2018 and held it in 12 quarters.
Ameritas Investment Partners's Translate Bio, Inc. Common Stock position peaked at $145K in Q2 2021.
0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Ameritas Investment Partners's 13F filing for Q3 2021, filed 15 Nov 2021.